Loading viewer...
conference
Format: PDF conference
Spark Therapeutics presented its validated gene therapy platform at the Cowen Health Care Conference, showcasing human proof-of-concept data for voretigene neparvovec in inherited retinal disease and SPK-9001 in hemophilia B. The company highlighted breakthrough therapy designations, preliminary clinical data demonstrating efficacy and durability, and a rolling BLA submission targeting 2017 FDA approval.
brochure
conference
30 Pages
IDEXX Laboratories
SS&C Technologies 2023 Needham Growth Conference Presentation
conferenceconference
18 Pages
SS&C Technologies Holdings, Inc.